National Institute on Drug Abuse; Notice of Closed Meeting

• Published date: 09 September 2021
• Citation: 86 FR 50545
• Record Number: 2021-19408
• Section: Notices
• Court: National Institutes Of Health

Federal Register, Volume 86 Issue 172 (Thursday, September 9, 2021)

[Federal Register Volume 86, Number 172 (Thursday, September 9, 2021)]
                [Notices]
                [Pages 50545-50546]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2021-19408]
                -----------------------------------------------------------------------
                DEPARTMENT OF HEALTH AND HUMAN SERVICES
                National Institutes of Health
                National Institute on Drug Abuse; Notice of Closed Meeting
                 Pursuant to section 10(d) of the Federal Advisory Committee Act, as
                [[Page 50546]]
                amended, notice is hereby given of the following meeting.
                 The meeting will be closed to the public in accordance with the
                provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
                U.S.C., as amended. The grant applications and the discussions could
                disclose confidential trade secrets or commercial property such as
                patentable material, and personal information concerning individuals
                associated with the grant applications, the disclosure of which would
                constitute a clearly unwarranted invasion of personal privacy.
                 Name of Committee: National Institute on Drug Abuse Special
                Emphasis Panel; Single Cell Opioid Responses in the Context of HIV
                (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid,
                Methamphetamine, and/or Cocaine Exposures (U01 Clinical Trial Not
                Allowed).
                 Date: October 18, 2021.
                 Time: 11:00 a.m. to 5:00 p.m.
                 Agenda: To review and evaluate grant applications.
                 Place: National Institutes of Health, National Institute on Drug
                Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892 (Virtual
                Meeting).
                 Contact Person: Yvonne Owens Ferguson, Ph.D., Scientific Review
                Officer, Office of Extramural Policy and Review, Division of
                Extramural Research, National Institute on Drug Abuse, NIH, 301
                North Stonestreet Avenue, MSC 6021, Bethesda, MD 20892, (301) 402-
                7371, [email protected].
                (Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
                Abuse Scientist Development Award for Clinicians, Scientist
                Development Awards, and Research Scientist Awards; 93.278, Drug
                Abuse National Research Service Awards for Research Training;
                93.279, Drug Abuse and Addiction Research Programs, National
                Institutes of Health, HHS)
                 Dated: September 2, 2021.
                Tyeshia Roberson-Curtis,
                Program Analyst, Office Federal Advisory Committee Policy.
                [FR Doc. 2021-19408 Filed 9-8-21; 8:45 am]
                BILLING CODE 4140-01-P